Page last updated: 2024-10-30

6-anilino-5,8-quinolinedione and Hepatocellular Carcinoma

6-anilino-5,8-quinolinedione has been researched along with Hepatocellular Carcinoma in 2 studies

6-anilino-5,8-quinolinedione: structure given in first source; SRS-A & guanylate cyclase antagonist
6-anilino-5,8-quinolinedione : A quinolone that is quinoline-5,8-dione in which the hydrogen at position 6 is replaced by an anilino group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Díaz-Troya, S1
Najib, S1
Sánchez-Margalet, V1
Sugawara, J1
Suh, DS1
Faessen, GH1
Suen, LF1
Shibata, T1
Kaper, F1
Giaccia, AJ1
Giudice, LC1

Other Studies

2 other studies available for 6-anilino-5,8-quinolinedione and Hepatocellular Carcinoma

ArticleYear
eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells.
    Regulatory peptides, 2005, Feb-15, Volume: 125, Issue:1-3

    Topics: Aminoquinolines; Animals; Arginine; Calcium; Carbazoles; Carcinoma, Hepatocellular; Cell Enlargement

2005
Regulation of insulin-like growth factor-binding protein-1 by nitric oxide under hypoxic conditions.
    The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:8

    Topics: Alkaloids; Aminoquinolines; Base Sequence; Binding Sites; Carbazoles; Carcinoma, Hepatocellular; Cel

2000